Target Healthcare REIT (LON:THRL) Stock Price Crosses Above Fifty Day Moving Average - Here's Why

Key Points

• Target Healthcare REIT's share price moved above its 50-day moving average (50‑day MA GBX 103.68), trading as high as GBX 106.63 and last at GBX 105.89 on a volume of 1,098,222 shares.
• The company has a market cap of £656.79 million with a PE ratio of 8.42, a PEG of 1.48 and a beta of 0.53, suggesting relatively low valuation and volatility.
• It reported quarterly EPS of GBX 3.38, with a net margin of 104.45% and ROE of 10.73%, and analysts forecast about 6.22 EPS for the year; the REIT invests in modern, purpose‑built UK care homes to generate income and potential capital growth.

Target Healthcare REIT (LON:THRL - Get Free Report)'s share price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 103.68 and traded as high as GBX 106.63. Target Healthcare REIT shares last traded at GBX 105.89, with a volume of 1,098,222 shares trading hands.

Target Healthcare REIT Stock Performance

The firm's 50 day moving average price is GBX 103.68 and its two-hundred day moving average price is GBX 99.35. The firm has a market cap of £656.79 million, a PE ratio of 8.42, a PEG ratio of 1.48 and a beta of 0.53.

Target Healthcare REIT (LON:THRL - Get Free Report) last announced its quarterly earnings data on Wednesday, March 18th. The company reported GBX 3.38 earnings per share for the quarter. Target Healthcare REIT had a net margin of 104.45% and a return on equity of 10.73%. On average, analysts forecast that Target Healthcare REIT will post 6.2219101 earnings per share for the current year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.